Elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophilia.
The syndrome of episodic angioedema and eosinophilia is characterized by cyclic edema, marked peripheral blood eosinophilia, and eosinophil degranulation in the dermis. Using a sensitive immunoenzymetric method, we measured serum interleukin (IL)-5 levels in four patients with this syndrome. We also determined the percentage of activated T cells in the peripheral blood of a new patient before and during an attack. In the patient presented, IL-5 levels peaked several days before maximal eosinophilia and then declined. This patient's lymphocytes showed an increased percentage, 28% (normal 2% to 3%), of activated T cells staining for both CD3 and HLA-DR 10 days before maximal eosinophilia, but no increase at the time of peak eosinophilia. In serum from three previously reported cases, elevated serum IL-5 levels were found during attacks. After glucocorticoid administration, IL-5 levels became undetectable in three of the four patients. Production of IL-5 is likely an important determinant of the pathophysiology of this syndrome.
Butterfield
J H
JH
Division of Allergic Diseases and Internal Medicine, Mayo Clinic, Rochester, MN 55905.
Leiferman
K M
KM
Abrams
J
J
Silver
J E
JE
Bower
J
J
Gonchoroff
N
N
Gleich
G J
GJ
D000328:Adult; D000799:Angioedema / Q000097:blood*; D001835:Body Weight; D015550:Cell Degranulation; D004802:Eosinophilia / Q000097:blood*; D004804:Eosinophils / Q000502:physiology; D005260:Female; D006801:Humans; D015848:Interleukin-5 / Q000097:blood*; D010507:Periodicity; D011241:Prednisone / Q000627:therapeutic use; D013577:Syndrome; D016176:T-Lymphocyte Subsets / Q000276:immunology
D015848:Interleukin-5; D011241:Prednisone